Matches in SemOpenAlex for { <https://semopenalex.org/work/W143040108> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- W143040108 endingPage "30" @default.
- W143040108 startingPage "123" @default.
- W143040108 abstract "Combination of drugs from different classes of antihypertensives provides an additional antihypertensive effect thus minimising the probability of adverse effects related to the dose of antihypertensive. Combination therapy is indicated for the following groups of hypertensive patients: (a) all hypertensive patients whose systolic blood pressure exceeds the target systolic blood pressure value by > 20 mm Hg, or whose diastolic blood pressure exceeds the target diastolic blood pressure value by > 10 mm Hg; (b) in patients with diabetes mellitus (because the target values are < 130/80 mm Hg); (c) patients with target organ damage; (d) patients with a kidney or cardiovascular disease (patients with IHD, patients after a cerebrovascular accident); (e) patients with overall cardiovascular risk according the SCORE > or = 5%. The advantage of fixed combinations resides in the fact that they increase compliance with treatment by reducing the number of pills taken by the patients. A fixed combination of the ACE inhibitor perindopril and the calcium channel blocker amlodipine proves optimal as has been shown by the results of the ASCOT-BPLA study. The launch of the above combination on this market should therefore be welcome. The fixed combination of perindopril and amlodipine will be indicated for hypertensive patients with uncontrolled hypertension or cardiovascular risk factors. This fixed combination will also be ideal for patients with a higher risk of diabetes mellitus, i.e. patients with a higher fasting glycaemia, in patients with impaired glucose tolerance and in patients with the metabolic syndrome. We strongly believe that it will improve the control of hypertension in our hypertensive patients, and improve the cardioprotective and nephroprotective effect of hypertension therapy." @default.
- W143040108 created "2016-06-24" @default.
- W143040108 creator A5067138455 @default.
- W143040108 date "2009-02-01" @default.
- W143040108 modified "2023-09-25" @default.
- W143040108 title "[The combination of an ACE inhibitor and a calcium channel blocker is an optimal combination for the treatment of hypertension]." @default.
- W143040108 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19348394" @default.
- W143040108 hasPublicationYear "2009" @default.
- W143040108 type Work @default.
- W143040108 sameAs 143040108 @default.
- W143040108 citedByCount "2" @default.
- W143040108 countsByYear W1430401082015 @default.
- W143040108 countsByYear W1430401082022 @default.
- W143040108 crossrefType "journal-article" @default.
- W143040108 hasAuthorship W143040108A5067138455 @default.
- W143040108 hasConcept C126322002 @default.
- W143040108 hasConcept C134018914 @default.
- W143040108 hasConcept C164705383 @default.
- W143040108 hasConcept C27016395 @default.
- W143040108 hasConcept C2776999253 @default.
- W143040108 hasConcept C2779200603 @default.
- W143040108 hasConcept C2779611605 @default.
- W143040108 hasConcept C2779646130 @default.
- W143040108 hasConcept C2780356492 @default.
- W143040108 hasConcept C555293320 @default.
- W143040108 hasConcept C57900726 @default.
- W143040108 hasConcept C71924100 @default.
- W143040108 hasConcept C84393581 @default.
- W143040108 hasConceptScore W143040108C126322002 @default.
- W143040108 hasConceptScore W143040108C134018914 @default.
- W143040108 hasConceptScore W143040108C164705383 @default.
- W143040108 hasConceptScore W143040108C27016395 @default.
- W143040108 hasConceptScore W143040108C2776999253 @default.
- W143040108 hasConceptScore W143040108C2779200603 @default.
- W143040108 hasConceptScore W143040108C2779611605 @default.
- W143040108 hasConceptScore W143040108C2779646130 @default.
- W143040108 hasConceptScore W143040108C2780356492 @default.
- W143040108 hasConceptScore W143040108C555293320 @default.
- W143040108 hasConceptScore W143040108C57900726 @default.
- W143040108 hasConceptScore W143040108C71924100 @default.
- W143040108 hasConceptScore W143040108C84393581 @default.
- W143040108 hasIssue "2" @default.
- W143040108 hasLocation W1430401081 @default.
- W143040108 hasOpenAccess W143040108 @default.
- W143040108 hasPrimaryLocation W1430401081 @default.
- W143040108 hasRelatedWork W143040108 @default.
- W143040108 hasRelatedWork W1964480396 @default.
- W143040108 hasRelatedWork W1993376688 @default.
- W143040108 hasRelatedWork W2030083921 @default.
- W143040108 hasRelatedWork W2041215826 @default.
- W143040108 hasRelatedWork W2073774399 @default.
- W143040108 hasRelatedWork W2091904198 @default.
- W143040108 hasRelatedWork W2801161412 @default.
- W143040108 hasRelatedWork W2150192332 @default.
- W143040108 hasRelatedWork W2787280718 @default.
- W143040108 hasVolume "55" @default.
- W143040108 isParatext "false" @default.
- W143040108 isRetracted "false" @default.
- W143040108 magId "143040108" @default.
- W143040108 workType "article" @default.